The Foundations in #Oncopharm series returns with the story of a failed contraceptive candidate that became the first (?) targeted therapy for use in cancer. Tamoxifen's use, MOA, toxicities, and drug interactions are also discussed.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
